Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA.

Lisa M HessZhanglin Lin CuiDaniel S MytelkaYimei HanRobert GoodloeWilliam Schelman

Published in: International journal of colorectal disease (2019)

Patients diagnosed with metastatic colorectal cancer lived less than 2 years in this real-world database. While the time to initiation of second-line therapy was by definition longer among patients without rapidly progressing disease, survival outcomes were comparable from initiation of second-line therapy.

Keyphrases

metastatic colorectal cancer
end stage renal disease
ejection fraction
newly diagnosed
emergency department
combination therapy
patient reported
adverse drug
drug induced